1001-5256
2013 Issue 2
Current perspectives on the efficacy and mechanisms of combination therapy for chronic hepatitis B virus
ZHANG Xinxin.
ZHANG Xinxin.
..............page:81-83
Recent perspectives on the pathogenesis of hepatitis E
WANG Jingjing;TIAN Deying.
WANG Jingjing;TIAN Deying.
..............page:84-87
..............page:83
Recent progress in research of hepatitis B viruses with precore and basic core promoter mutations
LI Jin’e;CHEN Xinyue.
LI Jin’e;CHEN Xinyue.
..............page:88-92
Grading antiviral therapy in HCV-infected cirrhotic patients
ZHANG Ying;WEI Xin;JIA Zhansheng.
ZHANG Ying;WEI Xin;JIA Zhansheng.
..............page:93-96
la mi fu ding en ti ka wei he ti nuo fu wei zhi liao yi xing gan yan xiang guan gan ying hua de chang qi liao xiao yu an quan xing
zhu xiao jia yang li
zhu xiao jia yang li
..............page:96
..............page:96
..............page:169
yao wu you dao xing zi shen mian yi xing gan yan : lin chuang te zheng yu yu hou
he fang hui gao run ping
he fang hui gao run ping
..............page:169
Evaluation of telbivudine’s efficacy for treating HBeAg-positive chronic B hepatitis patients and identification of its predictive factors by logistic regression analysis
GUO Ruyi;YU Xueping;SU Zhijun;et al.
GUO Ruyi;YU Xueping;SU Zhijun;et al.
..............page:97-100
Clinical trial of telbivudine in the treatment of chronic hepatitis B in patients during the third trimester of pregnancy
JIANG Xiunong;FAN Lingyan;LI Dezhou;et al.
JIANG Xiunong;FAN Lingyan;LI Dezhou;et al.
..............page:101-103
Evaluation of adverse reactions induced by adefovir dipivoxil in 85 chronic hepatitis B patients
RUAN Bingwei;LU Xiaoju;LIN Yanming;et al.
RUAN Bingwei;LU Xiaoju;LIN Yanming;et al.
..............page:104-106
Evaluation of the therapeutic efficacy of lamivudine combined with plasma exchange for treating acute-on-chronic hepatitis B liver failure
HU Qijiang;JIANG Ying’an.
HU Qijiang;JIANG Ying’an.
..............page:107-109
Short-term and long-term efficacy of antiviral treatment of patients with HBV-associated acute-on-chronic liver failure
JIANG Lisheng;LI Yongguo;CHEN Shu;et al.
JIANG Lisheng;LI Yongguo;CHEN Shu;et al.
..............page:110-113
Hemodynamic effects of partial splenic artery embolization in patients with liver cirrhosis and portal hypertension
DUAN Liwei;SUN Han;CHEN Yongsheng;et al.
DUAN Liwei;SUN Han;CHEN Yongsheng;et al.
..............page:142-145
Age-related clinical features of autoimmune hepatitis
LI Yanli;ZHAO Yan;ZHAO Dantong;et al.
LI Yanli;ZHAO Yan;ZHAO Dantong;et al.
..............page:146-149
Influence of quantitative changes in HBeAg on the therapeutic efficacy of antiviral drugs
XIE Zhiwei;ZHOU Fuyuan.
XIE Zhiwei;ZHOU Fuyuan.
..............page:150-152,157
Effects of hepatitis C virus and antiviral treatment on thyroid function and thyroid autoantibody levels
QI Chuanwang;CHEN Qian;ZHANG Hui;et al.
QI Chuanwang;CHEN Qian;ZHANG Hui;et al.
..............page:153-157
Recent perspectives on the role of microRNAs of the miR-15 family in liver disease
MA Lixia;WEI Xinhuan;ZHANG Jing.
MA Lixia;WEI Xinhuan;ZHANG Jing.
..............page:158-161
..............page:161
Key points of the AASLD’s guidelines on hepatitis B diagnosis and treatment
XU Ying;LIU Yu;SUN Jian.
XU Ying;LIU Yu;SUN Jian.
..............page:162-169
Key points of the AASLD’s guidelines on hepatitis C diagnosis and treatment
YANG Ming;RAO Huiying.
YANG Ming;RAO Huiying.
..............page:170-175
Therapeutic efficacy of combination therapy with interferon and a nucleoside analogue for treating chronic hepatitis B patients
HE Yan;TANG Xiaopeng;ZHENG Xuanhe;et al.
HE Yan;TANG Xiaopeng;ZHENG Xuanhe;et al.
..............page:114-116,119
Analysis of occult hepatitis B virus infection among blood donors in Tangshan,China
CAO Xiao;CAO Qingbao;ZHANG Guoqiang;et al.
CAO Xiao;CAO Qingbao;ZHANG Guoqiang;et al.
..............page:117-119
Analysis of mutational patterns of the pre-C/C region of with hepatitis B virus in patients with HBV-associated acute-on-chronic liver failure
YAN Tao;LI Fan;LI Ke;et al.
YAN Tao;LI Fan;LI Ke;et al.
..............page:120-123,127
Expression of hypoxia-inducible factor-1 α in liver tissues of patients with chronic hepatitis B
DING Tilong;FAN Xiumei;WANG Yong;et al.
DING Tilong;FAN Xiumei;WANG Yong;et al.
..............page:124-127
Detection of HCV core antigen and its diagnostic significance
YANG Jie;CUI Jing;LIU Chun;et al.
YANG Jie;CUI Jing;LIU Chun;et al.
..............page:128-131
Characterization of peripheral blood lymphocyte subsets in hepatitis C virus-infected patients
LI Yuanyuan;JIN Lei;HE Jing;et al.
LI Yuanyuan;JIN Lei;HE Jing;et al.
..............page:132-135
The impact of HBV/HCV coinfection on HBV DNA levels and the severity of liver diseases in HBV-infected patients undergoing hemodialysis
ZHU Fusheng;QIN Yujie;CHENG Zhenjiang;et al.
ZHU Fusheng;QIN Yujie;CHENG Zhenjiang;et al.
..............page:136-137,141
Expression and significance of caspase-8 in chronic hepatitis
YANG Haifeng;XUE Ling;MIAO Yihui;et al.
YANG Haifeng;XUE Ling;MIAO Yihui;et al.
..............page:138-141
..............page:109